Comparison of Drug-Eluting Embolics versus Conventional Transarterial Chemoembolization for the Treatment of Patients with Unresectable Hepatocellular Carcinoma: A Cost-Effectiveness Analysis
Wu X, Chapiro J, Malhotra A, Kothary N. Comparison of Drug-Eluting Embolics versus Conventional Transarterial Chemoembolization for the Treatment of Patients with Unresectable Hepatocellular Carcinoma: A Cost-Effectiveness Analysis. Journal Of Vascular And Interventional Radiology 2020, 32: 2-12.e1. PMID: 33160827, DOI: 10.1016/j.jvir.2020.09.022.Peer-Reviewed Original ResearchAdolescentAdultAgedAged, 80 and overAntibiotics, AntineoplasticCarcinoma, HepatocellularChemoembolization, TherapeuticClinical Decision-MakingCost SavingsCost-Benefit AnalysisDecision Support TechniquesDecision TreesDisease ProgressionDoxorubicinDrug CarriersDrug CostsFemaleHumansLiver NeoplasmsMaleMiddle AgedModels, EconomicQuality of LifeQuality-Adjusted Life YearsTime FactorsTreatment OutcomeYoung Adult